EcoDrugPlus

Ensembl ID : ENSLBEG00000013930
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSLBEG00000019872
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSLBEG00000003322
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSLBEG00000027726
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSLBEG00000003291
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSLBEG00000018115
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSLBEG00000005149
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSLBEG00000007637
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSLBEG00000012323
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSLBEG00000007666
Gene Symbol: -
Cross references: -
354 Possible Orthologues:

Ensembl ID : ENSLBEG00000018871
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSLBEG00000007946
Gene Symbol: -
Cross references: -
108 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).